Drugs Affecting Blood and Blood Formation Practice Questions

Q: Heparin is the commonly used anticoagulant in cardiac surgery. Which of the following statements about heparin is FALSE?

It is the weakest acid found in living beings.. ### Explanation **1. Why Option A is the Correct (False) Statement:** Heparin is actually the **strongest organic acid** found in the human body. It is a highly sulfated glycosaminoglycan with a high density of negative charges. This strong electronegativity is essential for its binding to antithrombin III and various proteins. Therefore, stating it is the "weakest acid" is factually incorrect. **2. Analysis of Incorrect Options (True Statements):** * **Option B:** Most commercial heparin is "Unfractionated Heparin" (UFH), primarily sourced from **porcine (pig) intestinal mucosa** or bovine (cow) lung. * **Option C:** Heparin acts indirectly. It binds to **Antithrombin III (AT-III)**, inducing a conformational change that accelerates the inactivation of clotting factors, primarily **Thrombin (IIa) and Factor Xa**, by 1,000 to 4,000 times. * **Option D:** Heparin-Induced Thrombocytopenia (HIT) is a serious immune-mediated adverse effect caused by IgG antibodies against the **Heparin-Platelet Factor 4 (PF4) complex**, leading to platelet activation and paradoxical thrombosis. **3. NEET-PG High-Yield Clinical Pearls:** * **Monitoring:** UFH is monitored using **aPTT** (intrinsic pathway). LMWH does not require routine monitoring but can be checked using **Anti-Factor Xa levels**. * **Antidote:** **Protamine sulfate** (a strong base) neutralizes heparin (a strong acid) via chemical antagonism. * **Drug of Choice:** Heparin is the anticoagulant of choice during **pregnancy** because its high molecular weight prevents it from crossing the placenta (unlike Warfarin, which is teratogenic). * **Cardiac Surgery:** Heparin is preferred in cardiopulmonary bypass due to its rapid onset and easy reversibility.

Q: A 90-year-old woman with a fractured neck of femur is receiving low-molecular-weight heparin (LMWH). Which of the following statements regarding LMWH is true?

Its anticoagulant effect is by binding to antithrombin III.. ### Explanation **1. Why the Correct Answer is Right:** Low-molecular-weight heparin (LMWH), like Enoxaparin or Dalteparin, exerts its anticoagulant effect by binding to **Antithrombin III (AT-III)**. This binding induces a conformational change in AT-III, which accelerates the inactivation of **Factor Xa**. Unlike Unfractionated Heparin (UFH), LMWH has a shorter polysaccharide chain, making it highly selective for Factor Xa inhibition with minimal effect on Thrombin (Factor IIa). **2. Why the Incorrect Options are Wrong:** * **Option A:** LMWH typically has a molecular weight ranging from **2,000 to 8,000 Daltons** (average ~4,500–5,000). Standard UFH is much larger (5,000–30,000 Daltons). * **Option C:** LMWH has a longer half-life and more predictable pharmacokinetics than UFH. It is typically administered **once or twice daily** subcutaneously, not three times. * **Option D:** LMWH has **higher and more consistent bioavailability** (~90%) compared to UFH (~20-30%) because it binds less to plasma proteins and endothelial cells. **3. NEET-PG High-Yield Pearls:** * **Monitoring:** Routine monitoring (aPTT) is **not required** for LMWH due to its predictable response. If needed (e.g., in pregnancy or renal failure), **Anti-Xa levels** are measured. * **Renal Clearance:** LMWH is primarily excreted by the kidneys; it is **contraindicated/used with caution in chronic kidney disease** (UFH is preferred here). * **HIT:** The risk of Heparin-Induced Thrombocytopenia (HIT) is significantly **lower** with LMWH than with UFH. * **Antidote:** Protamine sulfate only **partially neutralizes** LMWH (approx. 60%), whereas it completely reverses UFH.

Q: What is the most common adverse effect of oral anticoagulants?

Bleeding. **Explanation:** **1. Why Bleeding is the Correct Answer:** Oral anticoagulants (such as Warfarin, Dabigatran, Rivaroxaban, and Apixaban) work by inhibiting various steps of the coagulation cascade to prevent thrombus formation. Because these drugs systematically reduce the blood's ability to clot, the most common and predictable adverse effect is **bleeding** [2], [3]. This can range from minor bruising and epistaxis (nosebleeds) to occult gastrointestinal blood loss. **2. Analysis of Incorrect Options:** * **B. Hemorrhage:** While "bleeding" and "hemorrhage" are often used interchangeably in clinical practice, in the context of medical examinations, **bleeding** is the broader, more inclusive term for the adverse effect. Hemorrhage typically implies a more rapid, profuse, or life-threatening loss of blood [2]. Bleeding is the standard pharmacological term used to describe this class-wide side effect. * **C & D. Diarrhea and Vomiting:** While gastrointestinal upset can occur with almost any oral medication, these are not the primary or most common side effects associated with anticoagulants [1]. **3. High-Yield Clinical Pearls for NEET-PG:** * **Warfarin Monitoring:** Monitored using **PT/INR** (Target INR usually 2.0–3.0). * **Warfarin Necrosis:** A rare but serious side effect occurring in patients with Protein C or S deficiency [1], [2]. * **Antidotes:** * **Warfarin:** Vitamin K (slow), Fresh Frozen Plasma (FFP) or Prothrombin Complex Concentrate (PCC) (rapid) [2]. * **Dabigatran:** Idarucizumab. * **Rivaroxaban/Apixaban:** Andexanet alfa. * **Teratogenicity:** Warfarin is contraindicated in pregnancy (causes Fetal Warfarin Syndrome); **Heparin** is the anticoagulant of choice for pregnant women as it does not cross the placenta [2].

Q: Warm antibody hemolytic anemia is seen with which of the following drugs?

Methyldopa. **Explanation:** Drug-induced immune hemolytic anemia (DIIHA) occurs via different immunological mechanisms. Understanding these is crucial for NEET-PG. **1. Why Methyldopa is Correct:** Methyldopa causes hemolytic anemia through the **Autoantibody (True Autoimmune) Mechanism**. It induces the formation of IgG antibodies specifically directed against native Rh antigens on the red blood cell (RBC) surface. These are **"Warm" antibodies** (optimally active at 37°C). A key feature is that the Direct Antiglobulin Test (Coombs test) remains positive even in the absence of the drug in the test system, as the antibody targets the RBC itself, not the drug. **2. Analysis of Incorrect Options:** * **Quinine:** Operates via the **"Innocent Bystander" (Immune Complex) mechanism**. The drug binds to a plasma protein, forming a complex that elicits IgM antibodies. These complexes settle on RBCs, activate complement, and cause intravascular hemolysis. * **Penicillin:** Operates via the **Hapten/Drug Adsorption mechanism**. The drug binds to the RBC membrane; antibodies (IgG) then target the drug-membrane complex. Hemolysis usually occurs only with high-dose intravenous therapy. * **Aminophylline:** This is a methylxanthine used in airway obstruction; it is not associated with immune-mediated hemolytic anemia. **Clinical Pearls for NEET-PG:** * **Methyldopa Fact:** About 15-20% of patients on long-term Methyldopa develop a positive Coombs test, but only <1% develop clinically significant hemolysis. * **Warm vs. Cold:** Warm antibodies (IgG) typically cause extravascular hemolysis (spleen), while Cold antibodies (IgM) are associated with infections (Mycoplasma) or malignancies. * **Other Drugs:** Procainamide and Fludarabine can also cause the Methyldopa-type autoimmune reaction.

Q: Heparin acts by potentiating the activity of which of the following?

Antithrombin III. **Explanation:** **Mechanism of Action (Why A is correct):** Heparin is an indirect-acting anticoagulant [1]. It works by binding to **Antithrombin III (AT-III)**, a natural plasma protease inhibitor [1][2]. This binding induces a conformational change in AT-III, accelerating its activity by nearly 1,000-fold [2]. The activated AT-III then inactivates clotting factors, primarily **Thrombin (Factor IIa)** and **Factor Xa**, as well as factors IXa, XIa, and XIIa [1]. **Analysis of Incorrect Options:** * **B (Factor VIII) and D (Factor V):** These are co-factors in the coagulation cascade [1]. Heparin does not potentiate them; rather, by inhibiting Thrombin (IIa), heparin indirectly prevents the activation of Factor V and VIII, which require thrombin for their activation [1]. * **C (Thromboplastin):** Also known as Tissue Factor (Factor III), it initiates the extrinsic pathway. Heparin does not act on thromboplastin; instead, it inhibits the downstream proteases triggered by it. **High-Yield NEET-PG Pearls:** * **Monitoring:** The efficacy of Unfractionated Heparin (UFH) is monitored using **aPTT** (intrinsic pathway). Low Molecular Weight Heparin (LMWH) does not require routine monitoring but can be checked using **Anti-Factor Xa levels** [2]. * **Antidote:** The specific antidote for heparin overdose is **Protamine Sulfate** [2]. * **Side Effects:** The most unique side effect is **Heparin-Induced Thrombocytopenia (HIT)**, caused by IgG antibodies against the Heparin-Platelet Factor 4 complex [2]. * **LMWH vs. UFH:** LMWH (e.g., Enoxaparin) has a higher ratio of Anti-Xa to Anti-IIa activity and a longer half-life compared to UFH [2].

Q: Which of the following does not cause megaloblastic anemia?

Chloroquine. **Explanation:** Megaloblastic anemia is primarily caused by a deficiency in **Vitamin B12 (Cobalamin)** or **Folic Acid**, which leads to impaired DNA synthesis and the characteristic "nuclear-cytoplasmic asynchrony." **Why Chloroquine is the correct answer:** Chloroquine is an aminoquinoline used for malaria and rheumatoid arthritis. It does not interfere with folate metabolism, B12 absorption, or DNA synthesis. Therefore, it is **not** associated with megaloblastic anemia. Its primary hematologic side effect (though rare) is hemolysis in patients with G6PD deficiency. **Why the other options are incorrect:** * **Phenytoin:** This antiepileptic drug inhibits the enzyme *intestinal conjugase*, reducing the absorption of dietary folates. Long-term use frequently leads to folate deficiency and megaloblastic anemia. * **Sulfasalazine:** Used in inflammatory bowel disease (IBD), it inhibits the *reduced folate carrier (RFC)*, significantly impairing folate absorption in the jejunum. * **Alcohol:** Chronic alcohol consumption is a common cause of macrocytosis. It has a direct toxic effect on bone marrow and interferes with the enterohepatic circulation of folate, leading to rapid depletion of stores. **High-Yield Clinical Pearls for NEET-PG:** * **DHFR Inhibitors:** Methotrexate, Pyrimethamine, and Trimethoprim are classic causes of megaloblastic anemia (they prevent the conversion of DHF to THF). * **DNA Synthesis Inhibitors:** Hydroxyurea, Zidovudine (AZT), and 5-Fluorouracil can cause megaloblastic changes without actual folate/B12 deficiency. * **Prophylaxis:** Patients on long-term Phenytoin or Methotrexate should always receive folic acid supplementation.

Q: Which of the following BEST describes the mechanism of action of aspirin?

Aspirin irreversibly inhibits platelets. **Mechanism of Action of Aspirin** **Correct Answer Explanation:** Aspirin (Acetylsalicylic acid) acts by **irreversibly inhibiting the enzyme Cyclooxygenase-1 (COX-1)** [1]. It achieves this by acetylating a specific serine residue at the active site of the enzyme [2]. In platelets, COX-1 is responsible for converting arachidonic acid into **Thromboxane A2 (TXA2)**, a potent vasoconstrictor and platelet aggregator [2]. Because platelets are anucleated fragments, they cannot synthesize new enzymes. Therefore, the inhibition lasts for the entire lifespan of the platelet (**7–10 days**). This unique irreversible action is why low-dose aspirin is effective for secondary prophylaxis of MI and stroke [1]. **Analysis of Incorrect Options:** * **Options A & B:** Aspirin has no direct effect on the synthesis or serum levels of clotting factors like **Factor VIII or Factor IX**. These factors are part of the coagulation cascade, which is typically targeted by anticoagulants (like Heparin or Warfarin), not antiplatelet drugs. * **Option D:** Aspirin does not inhibit **Thrombin** (Factor IIa). Direct Thrombin Inhibitors (DTIs) include drugs like Dabigatran, Argatroban, and Bivalirudin. **High-Yield NEET-PG Pearls:** * **Low dose (75–150 mg):** Predominantly inhibits TXA2 (Antiplatelet effect) [1]. * **High dose:** Inhibits Prostacyclin (PGI2) in vascular endothelium, though endothelium can regenerate COX, unlike platelets. * **Zero-order kinetics:** Aspirin follows zero-order elimination at high/toxic doses. * **Reye’s Syndrome:** Avoid aspirin in children with viral infections (except in Kawasaki disease). * **Aspirin Triad (Samter’s):** Asthma, Nasal polyposis, and Aspirin sensitivity.

Q: Which of the following anticoagulants does not require routine laboratory coagulant profile monitoring?

Dabigatran. The correct answer is **Dabigatran**.Why Dabigatran is correct:Dabigatran is a **Direct Thrombin Inhibitor (DTI)** administered orally. Unlike traditional anticoagulants, it has a predictable pharmacokinetic and pharmacodynamic profile with a wide therapeutic window [3]. Therefore, it does not require routine laboratory monitoring (like PT/INR or aPTT) in most clinical scenarios [3]. This is a major advantage of **NOACs (Novel Oral Anticoagulants)**, which also include Factor Xa inhibitors like Rivaroxaban and Apixaban [1].Why the other options are incorrect:* **Warfarin:** This vitamin K antagonist has a narrow therapeutic index and significant inter-individual variability. It requires frequent monitoring of the **Prothrombin Time (PT)**, reported as the **International Normalized Ratio (INR)**, to prevent bleeding or thrombosis.* **Heparin (Unfractionated):** Due to its unpredictable binding to plasma proteins, UFH requires close monitoring using the **activated Partial Thromboplastin Time (aPTT)** to maintain a therapeutic range (usually 1.5–2.5 times the control) [4].* **Argatroban:** Although it is a DTI like Dabigatran, it is administered intravenously (usually for Heparin-Induced Thrombocytopenia) and requires **aPTT monitoring** to ensure safe dosing [2].**High-Yield NEET-PG Pearls:**1. **Antidote for Dabigatran:** Idarucizumab (a humanized monoclonal antibody fragment).2. **Monitoring if needed:** If emergency monitoring for Dabigatran is required, **Ecarin Clotting Time (ECT)** or Dilute Thrombin Time (dTT) are the most sensitive tests, as aPTT is not linear.3. **LMWH (Enoxaparin):** Also generally does not require monitoring, but if needed (e.g., in pregnancy or renal failure), **Anti-Factor Xa levels** are measured [5].

Q: All of the following are adverse effects of unfractionated heparin except?

Thrombocytosis. **Explanation:** The correct answer is **Thrombocytosis** because Unfractionated Heparin (UFH) is classically associated with a decrease in platelet count (Thrombocytopenia), not an increase. **1. Why Thrombocytosis is the correct answer:** Heparin can cause **Heparin-Induced Thrombocytopenia (HIT)**. This occurs in two forms: * **Type I:** A mild, non-immunogenic transient drop in platelets. * **Type II:** A severe, immune-mediated reaction where antibodies form against the **Heparin-Platelet Factor 4 (PF4) complex**. This leads to platelet activation and paradoxical thrombosis despite a low platelet count. Since heparin causes a *reduction* in platelets, "Thrombocytosis" is the incorrect clinical effect. **2. Analysis of incorrect options:** * **Bleeding (Option D):** This is the **most common** adverse effect of heparin due to its primary action of activating Antithrombin III, which inhibits Thrombin (IIa) and Factor Xa. * **Osteoporosis (Option B):** Long-term heparin use (usually >6 months) stimulates osteoclasts and inhibits osteoblasts, leading to decreased bone density. This is a high-yield side effect often tested in the context of pregnancy. * **Alopecia (Option A):** Heparin can cause transient hair loss (telogen effluvium) starting 4–12 weeks after therapy. **Clinical Pearls for NEET-PG:** * **Antidote:** Protamine sulfate (1 mg neutralizes 100 units of UFH). * **Monitoring:** UFH is monitored using **aPTT** (intrinsic pathway). * **Hyperkalemia:** Heparin inhibits aldosterone synthesis in the adrenal glands, which can lead to increased potassium levels. * **Safe in Pregnancy:** Heparin does not cross the placenta, making it the anticoagulant of choice during pregnancy.

Question 1

Heparin is the commonly used anticoagulant in cardiac surgery. Which of the following statements about heparin is FALSE?

Accepted Answer

It is the weakest acid found in living beings.

Answer

Most commercial preparations of heparin are derived from pig intestine.

Answer

It acts by antithrombin activation.

Answer

It can produce thrombocytopenia.

Question 2

A 90-year-old woman with a fractured neck of femur is receiving low-molecular-weight heparin (LMWH). Which of the following statements regarding LMWH is true?

Accepted Answer

Its anticoagulant effect is by binding to antithrombin III.

Answer

It has molecular weight below 4000 daltons.

Answer

It should be administered two to three times a day.

Answer

It has lower bioavailability than standard heparin.

Question 3

What is the most common adverse effect of oral anticoagulants?

Accepted Answer

Bleeding

Answer

Hemorrhage

Answer

Diarrhea

Answer

Vomiting

Question 4

Warm antibody hemolytic anemia is seen with which of the following drugs?

Accepted Answer

Methyldopa

Answer

Quinine

Answer

Penicillin

Answer

Aminophylline

Question 5

Heparin acts by potentiating the activity of which of the following?

Accepted Answer

Antithrombin III

Answer

Factor VIII

Answer

Thromboplastin

Answer

Factor V

Question 6

Which of the following does not cause megaloblastic anemia?

Accepted Answer

Chloroquine

Answer

Phenytoin

Answer

Sulfasalazine

Answer

Alcohol

Question 7

Which of the following BEST describes the mechanism of action of aspirin?

Accepted Answer

Aspirin irreversibly inhibits platelets

Answer

Aspirin decreases the serum level of factor VIII

Answer

Aspirin decreases the serum level of factor IX

Answer

Aspirin irreversibly inhibits thrombin

Question 8

What are the common side effects of erythropoietin?

Accepted Answer

Hypertension

Answer

Increased ferritin

Answer

Thrombocytosis

Answer

Decreased phosphate

Question 9

Which of the following anticoagulants does not require routine laboratory coagulant profile monitoring?

Accepted Answer

Dabigatran

Answer

Warfarin

Answer

Argatroban

Answer

Heparin

Question 10

All of the following are adverse effects of unfractionated heparin except?

Accepted Answer

Thrombocytosis

Answer

Alopecia

Answer

Osteoporosis

Answer

Bleeding

Drugs Affecting Blood and Blood Formation — MCQs

Drugs Affecting Blood and Blood Formation — MCQs

On this page

Practice by Chapter

Want unlimited practice?